A Clinical Pharmacological Study of YM155 After Intravenous Infusion in Patients With Advanced Cancer
Clinical trial NCT01023386 · COMPLETED
Trial details
- NCT number
- NCT01023386
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-01
- Primary completion
- 2010-03-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.